supported by the Key Project of the National Natural Science Foundation of China(81920108018 to T.L.and P.S.);Ministry of Science and Technology of the People’s Republic of China(2022ZD0205200);Natural Science Foundation of Sichuan Province(2022NSFSC1607);Key R&D Program of Zhejiang(2022C03096 to T.L.);Special Foundation for Brain Research from Science and Technology Program of Guangdong(2018B030334001);Project for Hangzhou Medical Disciplines of Excellence&Key Project for Hangzhou Medical Disciplines;。
Ketamine, a rapid-acting antidepressant drug, has been used to treat major depressive disorder and bipolar disorder(BD). Recent studies have shown that ketamine may increase the potential risk of treatment-induced man...
Objective: to analyze the application value of targeted nursing. Methods: 90 patients with mania in our hospital were selected as the research object, from September 2020 to September 2021. All patients were divided i...
Objective To explore the application value of progressive guided nursing and advanced empathic nursing in patients with manic episodes of bipolar disorder. Method to amount of computer random method will be our hospit...
Objective: to analyze the effect of individualized nursing on patients with mania. Methods: 100 patients with mania were divided into the control group and the experimental group. Differential nursing was given and di...
BACKGROUND Nowadays there is an increasing use of transcranial magnetic stimulation(TMS)both in neurological and psychiatric fields.After Food and Drug Administration approval of TMS for the therapy of treatment-resis...
Objective: to explore the effect of escitalopram oxalate in the treatment of bipolar disorder. Methods: 80 patients with bipolar disorder were randomly selected as the object, and the hospitalization time was from Jan...
Background: After the March 2011 “triple” disaster in Japan, the residents of Fukushima Prefecture suffered from serious psychological stress. Aims: This study aimed to elucidate the influence of stressful condition...
Supported by In part Research Fellowship from the Sapienza Foundation,Rome(to Giulia S);by Fondazione Banco di Sardegna,Italy(to Gino S)
We review preclinical and clinical evidences strongly suggesting that memantine, an old drug currently approved for Alzheimer's dementia, is an effective treatment for acute mania and for the prevention of manic/hypom...